Alzheimer's Disease Market Research Reports & Industry Analysis
A gradual loss of neurons later in adulthood does not result in significant alteration in brain function during the usual life span. However, the older one gets, the greater the neurologic impairment. Excessive neuronal degeneration in adulthood is called Alzheimer’s disease or senile dementia and is distinguished from the normal changes in aging. Alzheimer’s disease is a progressive disease which results in death of the brain cells causing memory lapses, behavioral issues, and disruption of thinking processes. The disease is considered fatal. Age and generic inheritance are the two key risk factors for developing Alzheimer’s disease. These are also risk factors that are not preventable. However, other preventable risk factors have been linked to the development of AD, including environment, diet, and overall general health. A combination of risk factors is often responsible for the disease.
Alzheimer’s disease is estimated to affect up to 6% of the population over 65. Life expectancy has been increasing around the world due to advances in healthcare, medical research, sanitation, and nutrition. This provides a setting for a higher number of Alzheimer’s disease patients in the future as the population continues to add years to their life.
Alzheimer's Disease Industry Research & Market Reports
-
North America and South & Central America Medical Marijuana Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Product (Dried Form and Extract Form), Application (Pain Management, Tourette’s, Alzheimer’s Disease, Migraines, Depression and Anxiety, Multiple Sclerosis, Cancer, and Others), Distribution Channel (Retail Pharmacy, E-Commerce, and Others), and Regions
... Anxiety, Multiple Sclerosis, Cancer, and Others), Distribution Channel (Retail Pharmacy, E-Commerce, and Others), and Regions The North America and South & Central America medical marijuana market was valued at US$ 6,645.16 million in 2021 and ... Read More
-
Alzheimer's Disease Diagnostics and Therapeutics Market, By Product (Therapeutics [Cholinesterase Inhibitors, NMDA Receptor Antagonists, and Other Therapeutics] and Diagnostics [Brain Imaging and CSF Test for Alzheimer’s Disease]) and By Geography (North America, Europe, Asia-Pacific, Middle East and Africa, and South America) - Size, Share, Outlook, and Opportunity Analysis, 2022 - 2028
... East and Africa, and South America) - Size, Share, Outlook, and Opportunity Analysis, 2022 - 2028 Alzheimer's disease is a neurodegenerative disease that usually starts slowly and progressively worsens. It is a progressive form of ... Read More
-
Glycomic Therapeutics Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Class (Isolated and Synthetic), Structures [Glycoproteins, Targeting Sialic Acid, Proteoglycans, Targeting Glycosaminoglycans, Glycosylphosphatidylinositol (GPI)-Anchored Proteins & Heparin Based Glycans, Targeting Glycosphingolipids, and Others], Indications (Thrombosis & Chemoprophylaxis, Anaemia, Anti-Adhesive & Anti-Inflammatory, Cataracts, Gaucher’s Disease, MPS-1 & IV, Cancer, Alzheimer’s Disease, Influenza Type A & B, and Others), and Mode of Action [Inhibits Neuraminidase; Inhibits Heparanase and Selectins and Blocks Interactions Between Growth Factors and Heparan Sulfate; Erythropoietin & Enzyme Replacement Therapy (ERT); Tissue Plasminogen Activator; Inhibits Glucosylceramide Synthase; Interleukin 1, 2 & 3; Beta & Gamma Interferons; and Others]
... Others], Indications (Thrombosis & Chemoprophylaxis, Anaemia, Anti-Adhesive & Anti-Inflammatory, Cataracts, Gaucher’s Disease, MPS-1 & IV, Cancer, Alzheimer’s Disease, Influenza Type A & B, and Others), and Mode of Action [Inhibits Neuraminidase; Inhibits Heparanase and Selectins ... Read More
-
Medical Marijuana Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Product (Dried Form and Extract Form), Application (Pain Management, Tourette Syndrome, Alzheimer’s Disease, Migraines, Depression and Anxiety, Multiple Sclerosis, Cancer, and Others), Distribution Channel (Retail Pharmacy, E-Commerce, and Others), and Geography
... Distribution Channel (Retail Pharmacy, E-Commerce, and Others), and Geography The medical marijuana market was valued at US$ 11,706.50 million in 2021 and is likely to reach value of US$ 40,027.59 million by 2028; it is ... Read More
-
Latin America Alzheimer’s Disease Therapeutics And Diagnostics Market 2022-2028
... of CAGR over the forecast years from 2022-2028. Mexico, Brazil, and Rest of Latin America are analyzed in the market in this region. In 2019, a major international initiative for Alzheimer’s disease led by the ... Read More
-
North America Alzheimer’s Disease Therapeutics And Diagnostics Market 2022-2028
... over the forecast period from 2022 to 2028. The United States and Canada are evaluated in the market in this region. The United States accounts for the leading share in the AD therapeutics and diagnostics ... Read More
-
Europe Alzheimer’s Disease Therapeutics And Diagnostics Market 2022-2028
... duration of 2022-2028. Germany, Spain, the United Kingdom, Italy, France, and Rest of Europe are included in the market in this region. A network of “memory centers,” which specialize in neurodegenerative disease diagnosis, has been ... Read More
-
Middle East And Africa Alzheimer’s Disease Therapeutics And Diagnostics Market 2022-2028
... CAGR of 5.81% over the forecasting years 2022-2028. Turkey, the United Arab Emirates, Saudi Arabia, South Africa, and Rest of Middle East & Africa are scrutinized in the market in this region. Egypt, Qatar, Uganda, ... Read More
-
Asia-pacific Alzheimer’s Disease Therapeutics And Diagnostics Market 2022-2028
... over the forecast duration from 2022 to 2028. Japan, India, South Korea, China, Australia & New Zealand, ASEAN countries, and Rest of Asia-Pacific are assessed in the market in this region. South Korea’s population is ... Read More
-
Global Alzheimer’s Disease Therapeutics And Diagnostics Market 2022-2028
... Alzheimer’s disease (AD) and the growing elderly populace are key factors driving the growth of this market. The elderly population is at an increased risk of developing this disease, which is expected to aid the ... Read More
-
Post-Acute Market Reports
... is projected to reach $220.4 billion. Although the nation has an expanding senior population, in 2021 many skilled nursing and senior housing facilities operated at a financial loss. That trend is expected to continue throughout ... Read More
-
U.S. Digital Therapeutics Market - Industry Outlook and Forecast 2022-2027
... to the growth of the U.S. digital therapeutics market: Rise in Chronic Diseases and Need for Controlling Healthcare Costs Increase in Adoption of Healthcare Applications & Smart Wearables Rising Importance of A.I. in Digital Therapeutics ... Read More
-
Global Cognition and Memory Enhancement Market Size study, by Product & Service (Cognition & Memory-enhancing Drugs, Brain-boosting Nutraceuticals, Cognitive Assessment & Training Solutions) and Regional Forecasts 2022-2028
... at approximately USD 23 billion in 2021 and is anticipated to grow with a healthy growth rate of more than 10% over the forecast period 2022-2028. Cognitive and memory enhancer pharmaceuticals are supplements or medications ... Read More
-
2022 Global Forecast for Alzheimer'S Disease Diagnostic Market (2023-2028 Outlook)-High Tech & Emerging Markets Report
... countries. The global market is expected to increase from USD xx billion in 2022 to USD xx billion by 2028, at a CAGR of xx% from 2023 to 2028. Estimates on equipment or material sales ... Read More
-
Anti-Neprilysin Market, by Drug Type (Sacubitril, TD-0714, STR-324, PL-265, LHW-090, and Others), by Indication (Acute Heart Failure, Cancer Pain, Hypertension, Alzheimer’s Disease, and Others), by Distribution Channel (Hospitals Pharmacies, Retail Pharma
... by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) - Size, Share, Outlook, and Opportunity Analysis, 2022 - 2028 Anti-neprilysin drugs are majorly used for acute heart failure, cancer pain, hypertension, ... Read More
-
Tauopathies Treatment Market, by Disease (Frontoyemporal Degenration [Pick’s Disease, CBD, and PSP], Alzheimer’s Disease, and Other Neurodegenerative Diseases), by Distribution Channel (Hospital Pharmacy, Retail Pharmacy, and Online Sales), and by Region
... Europe, Asia Pacific, Middle East, and Africa) - Size, Share, Outlook, and Opportunity Analysis, 2022 - 2028 Tauopathies are clinically, morphologically, and biochemically heterogeneous neurodegenerative diseases that are characterized by the tau protein aggregation in ... Read More
-
Neurological Biomarkers Market, by Biomarker Type (Imaging Biomarkers, Metabolomics Biomarkers, Proteomic Biomarkers, and Genomics Biomarkers), by Application (Alzheimer’s Disease, Parkinson’s Disease, Multiple Sclerosis, Autism Spectrum Disorders, and Ot
... Centers, Research Organizations, and Others), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) - Size, Share, Outlook, and Opportunity Analysis, 2022 - 2028 Neurological biomarkers are biological indicators present ... Read More
-
Global Brain Biomarkers Market Size study, By Product Type (Biomarker Test Kits, Biomarker Analyzers), By Disease Indication (Stroke, MND & ALS, Alzheimer’s Disease & Other Dementias, Parkinson’s Disease, Huntington’s Disease), By Application (Diagnosis, Drug Discovery and Development, Others), By End User (Hospitals, Research Laboratories, Ambulatory Surgical Centers, Diagnostic Laboratories) and Regional Forecasts 2022-2028
... and Development, Others), By End User (Hospitals, Research Laboratories, Ambulatory Surgical Centers, Diagnostic Laboratories) and Regional Forecasts 2022-2028 Global Brain Biomarkers Market is valued approximately USD XX million in 2021 and is anticipated to grow ... Read More
-
Central Nervous System Disorders Therapeutics Market, by Disease Type (Neurodegenerative Disorders {Alzheimer’s Disease, Parkinson’s Disease, Multiple Sclerosis, and Others}, Infectious Diseases, Psychotic Disorders, Anxiety Disorders, Trauma, Mood Disord
... Agents, Anticonvulsants, Sedatives and Hypnotics, Antidepressants, Antipsychotics, and Others), by Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) - Size, ... Read More
-
Alzheimer’s Drugs Market Size and Share - Global Forecast, 2022 - 2028
... encounters various behavioral change with dementia, as a primary symptoms, which gets worse as disease progress. It majorly affects people of age group 65 and above. Currently, there is no therapeutic cure available for Alzheimer’s ... Read More
-
Alzheimer’s Therapeutics Market
... a comprehensive assessment of the most important market dynamics. On conducting thorough research on the historical as well as current growth parameters of the Alzheimer’s therapeutics market, the growth prospects of the market are obtained ... Read More
-
Alzheimer's Disease Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
... Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update, provides an overview of the Alzheimer's Disease (Central Nervous System) pipeline landscape. Alzheimer's disease is a progressive, degenerative condition causing damage to the memory ... Read More
-
Wearable Brain Devices Market Size, Share & Trends Analysis Report By Channel Type (32-Channel Type, 12-Channel Type), By Application (Medical Setting, AR/VR Gaming Settings), By End User, By Region, And Segment Forecasts, 2022 - 2030
... Wearable Brain Devices Market Growth & Trends The global wearable brain devices market size is anticipated to reach USD 668.5 million by 2030, registering a CAGR of 12.33%, according to a new report by Grand ... Read More
-
Global Psychedelic Drugs Market: Analysis By Indication (ADHD, MDD, Bipolar, Migraine, Anxiety, Parkinson’s Disease, OUD, Alzheimer’s Disease, AUD, TUD, Eating Disorder, and Narcolepsy) Size & Trends with Impact of Covid-19 and Forecast up to 2025
... Scope of the Report The report provides an in depth analysis of the global psychedelic drugs market by value, by indication, etc. The report also provides a detailed analysis of the COVID-19 impact on the ... Read More
-
Optogenetics Market - Growth, Trends, COVID-19 Impact, and Forecasts (2022 - 2027)
... a CAGR of 3.86% during 2022-2027. The ongoing COVID-19 pandemic globally is expected to have a significant impact on the optogenetics market. According to the article published by PUS University in February 2022, by Shanet ... Read More
Research Assistance
